#blood clots

UPDATED 7PM | Drug firm says those who received first dose should get the second, unless they suffer blood clots.

He says data shows only 168 cases of thrombosis detected worldwide since March from 21.6 million jabs.

Vaccines affected are based on a new technology using adenoviruses.

This follows concerns over Johnson & Johnson's vaccine which uses similar technology to CanSinoBIO's product.

Europe's drug regulator finds possible link between AstraZeneca's vaccine and very rare blood clots.